EDGAR Filing Documents for 0001193125-17-109077

Form 8-K - Current report:

SEC Accession No. 0001193125-17-109077

Filing Date

2017-04-04

Accepted

2017-04-04 06:01:58

Documents

Period of Report

2017-04-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d356774d8k.htm	8-K	28852
2	EX-10.1	d356774dex101.htm	EX-10.1	97528
3	EX-10.2	d356774dex102.htm	EX-10.2	52165
4	EX-10.3	d356774dex103.htm	EX-10.3	64651
5	EX-10.4	d356774dex104.htm	EX-10.4	65120
6	EX-99.1	d356774dex991.htm	EX-99.1	8225
7	GRAPHIC	g356774ex10_2pg13.jpg	GRAPHIC	1421
8	GRAPHIC	g356774g0404011421958.jpg	GRAPHIC	1146
9	GRAPHIC	g356774g04c70.jpg	GRAPHIC	3623
	Complete submission text file	0001193125-17-109077.txt		327288

Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931

Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011

PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)